Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: JAB-3068 Activity in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial update for JAB-3068 in adults with advanced solid tumors, including Esophageal Squamous Cell Carcinoma, No…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy [NA]
This completed clinical trial compares high-concentration small-volume iodine solution with low-concentration large-volume iodine solution f…
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
The clinical trial evaluating anastomotic leaks in patients with esophageal squamous cell carcinoma after trimodal therapy has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants [Phase 1, Phase 2]
Phase 1/2 study evaluating ASP0739 alone and in combination with pembrolizumab in NY-ESO-1 expressing advanced solid tumors was terminated, …
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: M6620 Plus Standard Treatment in Oesophageal and Other Cancer [Phase 1]
Phase 1 trial evaluating M6620 in combination with standard treatment for esophageal cancer (esophageal adenocarcinoma and esophageal squamo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating sintilimab after concurrent chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study) [Phase 2]
A Phase 2 BEAR study investigating BI-754091 in combination with Afatinib for refractory esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pre-operative pembrolizumab plus chemoradiation in locally advanced esophageal squamous cell carcinoma has complete…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating short-course radiotherapy plus sintilimab as neoadjuvant therapy for esophageal squamous cell carcinoma; the study …
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining a PD-1 inhibitor (sintilimab) with radiotherapy and immunonutrition for locall…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma [NA]
This clinical trial compares chemoradiotherapy versus esophagectomy after endoscopic resection for superficial esophageal squamous cell carc…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial evaluating toripalimab with paclitaxel and cisplatin vs. placebo with the same chemotherapy in advanced or metastatic esophage…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Multiorgan Metabolic Imaging Response Assessment of Abemaciclib [Phase 2]
Phase 2 trial update evaluating multiorgan metabolic imaging response assessment of abemaciclib.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer [Phase 3]
Phase 3 clinical trial evaluating KC1036 versus investigator's choice chemotherapy in advanced esophageal squamous cell carcinoma is current…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating toripalimab in combination with neoadjuvant chemotherapy and chemoradiotherapy for locally advanced unresectable es…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients [Phase 1, Phase 2]
Clinical trial update on immunotherapy with concurrent chemoradiotherapy followed by surgery for locally advanced esophageal squamous cell c…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC [Phase 3]
Phase 3 trial evaluating a PD-1 antibody plus mXELIRI versus mXELIRI alone in second-line esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial investigating anti-PD-L1 in combination with chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) [Phase 3]
A Phase 3 trial evaluating neoadjuvant chemoradiotherapy with either docetaxel or vinorelbine plus cisplatin for esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma [Phase 2, Phase 3]
A phase 2/3 trial comparing postoperative concurrent chemoradiotherapy to radiotherapy alone in locoregionally advanced esophageal squamous …
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC [Phase 2]
Phase 2 trial evaluating anti-PD-1 immunotherapy in combination with SBRT for patients with oligometastatic esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing tislelizumab versus chemotherapy as second-line treatment in advanced esophageal squamous cell carcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating extensive clinical target volumes in postoperative radiotherapy with concurrent chemotherapy for esophageal squamou…
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection [Phase 3]
A Phase 3 clinical trial update evaluating postoperative immune maintenance therapy for esophageal squamous cell carcinoma after radical res…